SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 15 filers reported holding SUMMIT THERAPEUTICS PLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,806,000 | -32.7% | 150,000 | -38.0% | 0.18% | -33.5% |
| Q4 2017 | $2,683,000 | -11.5% | 242,113 | 0.0% | 0.26% | -58.8% |
| Q3 2017 | $3,031,000 | +127.2% | 242,113 | +106.7% | 0.64% | +93.9% |
| Q2 2017 | $1,334,000 | -14.6% | 117,113 | 0.0% | 0.33% | -29.6% |
| Q1 2017 | $1,562,000 | +55.9% | 117,113 | 0.0% | 0.47% | -41.6% |
| Q4 2016 | $1,002,000 | +5.0% | 117,113 | +11.3% | 0.80% | +114.2% |
| Q3 2016 | $954,000 | +7.1% | 105,261 | -6.6% | 0.37% | -2.4% |
| Q2 2016 | $891,000 | -34.2% | 112,676 | -4.4% | 0.38% | +88.2% |
| Q4 2015 | $1,355,000 | +1.8% | 117,841 | -7.8% | 0.20% | -77.7% |
| Q3 2015 | $1,331,000 | -1.7% | 127,841 | -0.2% | 0.91% | +131.5% |
| Q2 2015 | $1,354,000 | -12.6% | 128,157 | +2.5% | 0.39% | -30.5% |
| Q1 2015 | $1,549,000 | – | 125,000 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Granite Point Capital Management, L.P. | 127,841 | $1,331,000 | 0.91% |
| SPHERA FUNDS MANAGEMENT LTD. | 205,200 | $2,136,000 | 0.27% |
| LANSDOWNE PARTNERS (UK) LLP | 930,000 | $9,681,000 | 0.08% |
| Point72 Asset Management, L.P. | 919,639 | $9,573,000 | 0.08% |
| EverPoint Asset Management, LLC | 100,000 | $1,041,000 | 0.03% |
| AXA S.A. | 376,205 | $3,916,000 | 0.02% |
| First Eagle Investment Management, LLC | 175,000 | $1,822,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 1,228 | $13,000 | 0.00% |
| UBS Group AG | 880 | $9,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,500 | $26,000 | 0.00% |